Brief: FDA Highlights Safety Concerns & Class I Recall for Getinge's Vasoview Hemopro Devices

Getinge publ AB

15/11/2024 15:08

Nov 15 (Reuters) - FDA: 
    * FDA: ALERTING HEALTH CARE PROVIDERS ABOUT SAFETY CONCERNS
WITH
GETINGE/MAQUET VASOVIEW HEMOPRO EVH SYSTEMS AND SUPPLY CONCERN
FOR EVH DEVICES- WEBSITE
    * FDA: WORKING WITH MANUFACTURER TO EVALUATE REPORTS OF
SILICONE
DETACHMENT WITH VASOVIEW HEMOPRO 2 (VH-4000 AND VH-4001) DEVICES
    * FDA: IDENTIFIED RECALL FOR VASOVIEW HEMOPRO 1.5 DEVICES AS
A
CLASS I RECALL
    * FDA: GETINGE/MAQUET RECEIVED 18 COMPLAINTS FOR HEMOPRO 1.5
DEVICES BETWEEN APRIL 1-JULY 31


 ((Reuters.Briefs@thomsonreuters.com;;))